Recently, Monteris Medical, a medical device company from Minnesota, USA, announced the completion of a $26.6 million Series C equity financing. This round of financing was led by Versant Ventures and SightLine Partners, and the company's existing investment institutions Birchview Capital and BDC Capital Healthcare Venture Fund also participated in this round of financing. Founded in 1999, Monteris Medical is headquartered in Plymouth, Minnesota, USA and has offices in Minneapolis, USA and Winnipeg, Canada. Monteris Medical is dedicated to the development of neurosurgical technology, focusing on the treatment of diseases such as brain damage and brain tumors beyond traditional methods through its NeuroBlate System, a minimally invasive laser ablation system. (Source: Star Tribune) According to the Central Brain Tumor Registry of the United States, more than 300,000 people in the United States are diagnosed with brain tumors and lesions each year. Currently, the NeuroBlate System has been sold as a surgical tool in the US and Australia, providing neurosurgery surgeons with a solution to replace traditional craniotomy. The NeuroBlate System combines magnetic resonance imaging (MRI), advanced navigation software, and laser interstitial therapy (LITT) to achieve precise ablation of deep brain lesions. According to Monteris Medical, the system is the only minimally invasive intracranial access system that safely and precisely controls the laser. (Source: Monteris Medical Website) anesthesia mask,anesthetic mask,anesthesia gas mask,anesthetic face mask 2 MEDS TECHONOLOGY CO.,LTD , https://www.2-meds.com
